Page last updated: 2024-09-05

tolvaptan and Obesity

tolvaptan has been researched along with Obesity in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Fujigaki, Y; Hayama, Y; Ishizawa, K; Sakai, K; Shibata, S; Tamura, Y; Ueno, M; Wang, Q; Yamazaki, O	1

Other Studies

2 other study(ies) available for tolvaptan and Obesity

Article	Year
Upregulation of renal Na-K-2Cl cotransporter 2 in obese diabetes mellitus via a vasopressin receptor 2-dependent pathway. Biochemical and biophysical research communications, 2020, 04-09, Volume: 524, Issue:3 Topics: Animals; Aquaporin 2; Diabetes Mellitus, Experimental; Disease Models, Animal; Kidney; Male; Mice; Obesity; Receptors, Vasopressin; Signal Transduction; Solute Carrier Family 12, Member 1; Tolvaptan; Up-Regulation; Uromodulin	2020
New drugs for prevention, relief. How you might benefit if 3 medications win FDA approval. Heart advisor, 2005, Volume: 8, Issue:10 Topics: Acetanilides; Angina Pectoris; Benzazepines; Heart Failure; Humans; Obesity; Piperazines; Piperidines; Pyrazoles; Ranolazine; Rimonabant; Tolvaptan	2005

Article

Year

Upregulation of renal Na-K-2Cl cotransporter 2 in obese diabetes mellitus via a vasopressin receptor 2-dependent pathway.

Biochemical and biophysical research communications, 2020, 04-09, Volume: 524, Issue:3

Topics: Animals; Aquaporin 2; Diabetes Mellitus, Experimental; Disease Models, Animal; Kidney; Male; Mice; Obesity; Receptors, Vasopressin; Signal Transduction; Solute Carrier Family 12, Member 1; Tolvaptan; Up-Regulation; Uromodulin

2020

New drugs for prevention, relief. How you might benefit if 3 medications win FDA approval.

Heart advisor, 2005, Volume: 8, Issue:10

Topics: Acetanilides; Angina Pectoris; Benzazepines; Heart Failure; Humans; Obesity; Piperazines; Piperidines; Pyrazoles; Ranolazine; Rimonabant; Tolvaptan

2005